Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes

Journal of Neuroimmunology

Volumn 68, Issue 1-2, 1996, Pages 27-38

  Delgado, Mario ^b   Martinez, Carmen ^b   Johnson, Mary C ^a   Gomariz, Rosa P ^b   Ganea, Doina ^a  

^a RUTGERS UNIVERSITY   (United States)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

T lymphocytes; Thymocytes; Vasoactive intestinal peptide receptors

Indexed keywords

CD3 ANTIGEN; NEUROPEPTIDE RECEPTOR; T LYMPHOCYTE RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ARTICLE; CELL LINE; DNA SEQUENCE; FEMALE; IMMUNOMODULATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0001808754     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5728(96)00063-X     Document Type: Article

References (62)

1. Beed E.A., O'Dorisio M.S., O'Dorisio T.M., Gaginella T.S. Demonstration of a functional receptor for VIP on Molt 4b T lymphoblasts. Regul. Pept. 6:1983;1-8.
2. Blum A.M., Mathew R., Cook G.A., Metwali A., Felman R., Weinstock J.V. Murine mucosal T cells have VIP receptors functionally distinct from those on epithelial cells. J. Neuroimmunol. 39:1992;101-108.
3. Boudard F., Bastide M. Inhibition of mouse T cell proliferation by CGRP and VIP. J. Neurosci. Res. 29:1991;29-41.
4. Calvo J.R., Guerrero J.M., Molinero P., Blasco R., Goberna R. Interactions of VIP with human peripheral blood lymphocytes. Gen. Pharmacol. 17:1986;185-189.
5. Calvo J.R., Molinero P., Jimenez J., Goberna R., Guerrero J.M. Interaction of VIP with rat lymphoid cells. Peptides. 7:1986;177-181.
6. Calvo J.J., Montilla M.L., Guerrero J.M., Segura J.J. Expression of VIP receptors in mouse peritoneal macrophages. J. Neuroimmunol. 50:1994;85-93.
7. Calvo J.J., Guerrero J.M., Lopez-Gonzalez A., Osuna C., Segura J.J. Characteristics of receptors for VIP in rat peritoneal macrophages. Peptides. 15:1994;309-315.
8. Cheng P.P.J., Sreedharan S.P., Kishiyama J.L., Goetzl E.J. The SKW 6.4 line of human B lymphocytes specifically binds and responds to VIP. Immunology. 79:1993;64-76.
9. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-162.
10. Christophe J., Cauvin A., Vervisch E., Buscail L., Damien C., Abello J., Gourlet P., Robberecht P. VIP receptors in human Sup-T1 lymphoblasts. Digestion. 46:1990;148-155.
11. Danek A., O'Dorisio M.S., O'Dorisio T.M., George J.M. Specific binding sites for VIP on nonadherent PBLs. J. Immunol. 131:1983;1173-1177.
12. De la Fuente M., Delgado M., del Rio M., Martinez C., Hernanz A., Gomariz R.P. Stimulation by VIP of phagocytic function in rat macrophages. Involvement of PKC activity. Regul. Pept. 48:1993;345-353.
13. De la Fuente M., Delgado M., DelRio M., Garrido E., Leceta J., Hernanz A., Gomariz R.P. VIP modulation of adherence and mobility in rat peritoneal lymphocytes and macrophages. Peptides. 15:1994;1157-1163.
14. Delgado, M., Martinez, M.C., Leceta, J., Garrido, E. and Gomariz, R.P. (1996) Differential VIP and VIP1-R receptor gene expression on rat thymocyte subsets. Peptides, in press.
15. Finch R.J., Sreedharan S.P., Goetzl E.J. High affinity receptors for VIP on human myeloma cells. J. Immunol. 142:1989;1977-1981.
16. Ganea D., Sun L. VIP downregulates the expression of IL-2 but not of IFNγ from stimulated murine T lymphocytes. J. Neuroimmunol. 47:1993;147-158.
17. Gomariz R.P., Garrido E., Leceta J., Martinez C., Abalo R., Delgado M. Gene expression of VIP receptor in rat lymphocytes. Biochem. Biophys. Res. Commun. 203:1994;1599-1604.
18. Gozes Y., Brenneman D.E., Fridkin M., Asofsky R., Gozes I. VIP antagonist distinguishes VIP-R on spinal cord cells and lymphocytes. Brain Res. 540:1991;319-321.
19. Guerrero J.M., Prieto J.C., Elorza F.L., Ramirez R., Goberna R. Interactions of VIP with human blood mononuclear cells. Mol. Cell. Endocrinol. 21:1981;151-160.
20. Hara T., Man Fu S. Human T cell activation. Monocyte-independent activation and proliferation induced by a T3 monoclonal antibody in the presence of tumor promoter 12-o-tetradecanoyl phorbol-13-acetate. J. Exp. Med. 161:1985;641-652.
21. Ichinose M., Sawada M., Maeno T. Inhibitory effect of VIP on phagocytosis in mouse peritoneal macrophages. Regul. Pept. 54:1994;457-466.
22. Inagaki N., Yoshida H., Mizuta M., Mizuno N., Fujii Y., Gonoi T., Miyazaki J., Susumu S. Cloning and functional characterization of a third PACAP receptor subtype expressed in insulin-secreting cells. Proc. Natl. Acad. Sci. USA. 91:1994;2679-2683.
23. Ishihara T., Shigemoto R., Mori K., Takahashi K., Nagata S. Functional expression and tissue distribution of a novel receptor for VIP. Neuron. 8:1992;811-819.
24. Johnson M., McCormack R., Delgado M., Martinez C., Ganea D. Murine T lymphocytes express vasoactive intestinal peptide receptor 1 (VIP-R1) mRNA. J. Neuroimmunol. 68:1996;109-119.
25. Krco T.J., Gores A., Go V.L.W. Gastrointestinal regulatory peptides modulate in vitro immune reactions of mouse lymphoid cells. Clin. Immunol. Immunopathol. 39:1986;308-318.
26. Laburthe M., Couvineau A. Molecular analysis of VIP receptors. A comparison with receptors for VIP-related peptides. Ann. New York Acad. Sci. 527:1988;296-302.
27. Lutz E.M., Sheward W.J., West K.M., Morrow J.A., Fink G., Harmar A.J. The VIP2 receptor: Molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS. 334:1993;3-8.
28. Maimone D., Cioni C., Rosa S., Macchia G., Aloisi F., Annunziata P. Norepinephrine and VIP induce IL-6 secretion by astrocytes: Synergism with IL-1β and TNFα J. Neuroimmunol. 47:1993;73-82.
29. Martinez C., Delgado M., Gomariz R.P., Ganea D. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating peptide (PACAP) inhibit IL-10 production in murine T lymphocytes. J. Immunol. 156:1996;4128-4136.
30. Mathew R.C., Cook G.A., Blum A.M., Metwali A., Felman R., Weinstock J.V. VIP stimulates T lymphocytes to release IL-5 in murine Schistosomiassis mansoni infection. J. Immunol. 148:1992;3572-3577.
31. Moore T.C., Spruck C.H., Said S.I. Depression of lymphocyte traffic in sheep by VIP. Immunology. 52:1988;511-518.
32. Nio D.A., Moylan R.N., Roche J.K. Modulation of T lymphocyte function by neuropeptides. J. Immunol. 150:1993;5281-5288.
33. O'Dorisio M.S., Hermina N.S., O'Dorisio T.M., Balcerzak P. VIP stimulation of adenylate cyclase in purified human leukocytes. J. Immunol. 127:1981;2551-2556.
34. O'Dorisio M.S., Wood C.L., Wenger D., Vassalo L.M. Cyclic AMP-dependent protein kinase in MOLT 4B lymphoblasts: Identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal peptide (VIP) and peptide histidine isoleucine (PHI). J. Immunol. 134:1985;4078-4083.
35. O'Dorisio M.S., Shannon B.T., Fleishman D.J., Campolito L.B. Identification of high affinity receptors for VIP on human lymphocytes of the B lineage. J. Immunol. 142:1989;3533-3536.
36. Ottaway C.A., Bernaerts C., Chan B., Greenberg G.R. Specific binding of VIP to human circulating mononuclear cells. Can. J. Physiol. Pharmacol. 61:1983;664-671.
37. Ottaway C.A., Greenberg G.R. Interaction of VIP with mouse lymphocytes. J. Immunol. 132:1984;417-423.
38. Ottaway C.A. Selective effects of VIP on the mitogenic response of murine T cells. Immunology. 62:1987;291-297.
39. Ottaway C.A., Lay T.E., Greenberg G.R. High affinity specific binding of VIP to human circulating T cells, B cells and large granular lymphocytes. J. Neuroimmunol. 29:1990;149-155.
40. Ottaway C.A. Receptors for VIP on murine lymphocytes turn over rapidly. J. Neuroimmunol. 38:1992;241-254.
41. Ottaway C.A. Insertion and internalization of VIP receptors in murine CD4 T lymphocytes. Regul. Pept. 41:1992;49-59.
42. Robberecht P., Abello J., Damien C., De Neef P., Vervisch E., Hooghe R., Christophe J. Variable stimulation of adenylate cyclase activity by vasoactive intestinal-like peptide and β-adrenergic agonist in murine T-cell lymphomas of immature, helper, and cytotoxic types. Immunobiology. 179:1989;422-431.
43. Robberecht P., Cauvin A., Gourlet P., Christophe J. Heterogeneity of VIP receptors. Arch. Int. Pharmacodyn. 303:1990;51-65.
44. Roberts A.I., Panja A., Brolin R.E., Ebert E.C. Human intraepithelial lymphocytes. Immunomodulation and receptor binding of VIP. Digest. Dis. Sci. 36:1991;341-346.
45. Robichon A., Sreedharan S.P., Yang J., Shames R.S., Gronroos E.C., Cheng P.P.J., Goetzl E.J. Induction of aggregation of Raji human B cells by VIP. Immunology. 79:1993;574-579.
46. Rola-Pleszczynski M., Bolduc D., St-Pierre S. The effects of VIP on NK function. J. Immunol. 135:1985;2569-2573.
47. Rouyer-Fessard C., Couvineau A., Voisin T., Laburthe M. Ac-Tyrl-hGRF discriminates VIP receptors from rat liver and intestinal epithelium. Life Sci. 45:1989;829-833.
48. Segura J.J., Guerrero J.M., Goberna R., Calvo J.R. Characterization of functional receptors for VIP in rat peritoneal macrophages. Regul. Pept. 35:1991;133-142.
49. Segura J.J., Guerrero J.M., Goberna R., Calvo J.R. Stimulatory effect of vasoactive intestinal peptide (VIP) on cyclic AMP production in rat peritoneal macrophages. Regul. Pept. 37:1992;195-203.
50. Spangelo B.L., Isakson P.C., MacLeod R.M. Production of IL-6 by anterior pituitary cells is stimulated by increased intracellular adenosine 3′5′-monophosphate and VIP. Endocrinology. 127:1990;403-409.
51. Sreedharan S.P., Patel D.R., Huang J.X., Goetzl E.J. Cloning and functional expression of a human VIP receptor. Biochem. Biophys. Res. Commun. 193:1993;546-553.
52. Stanitz A.M., Befus D., Bienenstock J. Differential effects of vasoactive intestinal peptide, substance P and somatostatin on Ig synthesis and proliferation by lymphocytes from Peyer's patches, mesenteric lymph nodes and spleen. J. Immunol. 136:1986;152-156.
53. Sun L., Ganea D. VIP inhibits IL-2 and IL-4 production through different mechanisms in T cells activated via the TCR/CD3 complex. J. Neuroimmunol. 48:1993;59-70.
54. Svoboda M., Tastenoy M., Van Rampelbergh J., Goossens J-F., De Neef P., Waelbroeck M., Robberecht P. Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts. Biochem. Biophys. Res. Commun. 205:1994;1617-1624.
55. Tang S.C., Braunsteiner H., Wiedermann C.J. Regulation of human T lymphoblast growth by sensory neuropeptides: Augmentation of cholecystokinin-induced inhibition of Molt-4 proliferation by somatostatin and vasoactive intestinal peptide. Immunol. Lett. 34:1992;237-242.
56. Tang H., Welton A., Ganea D. Neuropeptide regulation of cytokine expression. Effects of VIP and Ro 25-1553, a cyclic VIP analog on IL-2, IL-4 and IFNγ production by murine lymphocytes. J. Interferon Cytokine Res. 15:1995;993-1003.
57. Usdin T., Bonner T.I., Mezey E. Two receptors for VIP with similar specificity and complementary distributions. Endocrinology. 135:1995;2662-2681.
58. Van Lier R.A.W., Boot J.H.A., Verhoeven A.J., De Groot E.R., Brouwer M., Aarden L.A. Functional studies with CD3 heavy-chain isotype switch-variant monoclonal antibodies. Accessory cell-independent induction of IL-2 responsiveness in T cells by e-anti-CD3. J. Immunol. 139:1987;2873-2879.
59. Wiik P., Opstad P.K., Boyum A. Binding of VIP by human blood monocytes. Regul. Pept. 12:1985;145-163.
60. Wiik P. Homologous regulation of adenylate-cyclase coupled receptors for VIP on human mononuclear leukocytes. Regul. Pept. 20:1988;323-333.
61. Wiik P. VIP inhibits the respiratory burst in human monocytes by a cAMP-mediated mechanism. Regul. Pept. 25:1989;187-197.
62. Xin Z., Tang H., Ganea D. VIP inhibits IL-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex. J. Neuroimmunol. 54:1994;59-68.